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doi:10.1016/j.jtcvs.2007.12.021Objective: Progressive left ventricular remodeling after myocardial infarction has
been viewed as an important contributor to progressive heart failure. The objective
of this study was to investigate the relationship between myocardial apoptosis and
strain during progressive cardiac remodeling.
Methods: Before creation of an anterolateral left ventricular infarction by ligation of
diagonal arteries, 16 sonomicrometry transducers were placed in the left ventricular
free wall of 8 sheep to assess regional deformation in the infarct, adjacent, and nor-
mally perfused remote myocardial regions over 8 weeks’ duration. Hemodynamic,
echocardiographic and sonomicrometric data were collected before infarction and
then 30 minutes and 2, 6, and 8 weeks after infarction. At the end of the study, regional
myocardial tissues were collected for apoptotic signaling proteins.
Results: At terminal study, an increase in left ventricular end-diastolic pressure of 8.16
0.1 mm Hg, a decrease in ejection fraction from 54.19%6 5.68% to 30.55%6 2.72%,
and an end-diastolic volume increase of 46.086 5.02 mL as compared with the prein-
farct values were observed. The fractional contraction at terminal study correlated with
the relative abundance of apoptotic protein expressions: cytochrome c (r2 5 0.02,
P , .05), mitochondrial Bax (r2 5 0.27, P , .05), caspase-3 (r2 5 0.31, P , .05),
and poly (adenosine diphosphate–ribose) polymerase (r25 0.30,P, .05). These myo-
cardial apoptotic activities also correlated with remodeling strain: cytochrome c (r25
0.02,P, .05), mitochondrial Bax (r25 0.28,P, .05), caspase-3 (r25 0.43,P, .05),
and poly (adenosine diphosphate–ribose) polymerase (r25 0.37, P, .05).
Conclusion: Increase in regional remodeling strain led to an increase in myocardial
apoptosis and regional contractile dysfunction in heart failure.
C
ardiac remodeling after myocardial infarction (MI) is characterized by
progressive global left ventricular (LV) dilatation and systolic dysfunction
associated with an increased risk of congestive heart failure.1,2 Post-MI
remodeling has been described as a change in the structural properties between the
ischemic zone and the nonischemic zone that leads to increases in regional wall stress,
myocyte cell loss, side-to-side myocyte slippage, chronic lengthening, and hypertro-
phy of myocytes.3,4 Increased mechanical stresses in the myocardium during cardiacThe Journal of Thoracic and Cardiovascular Surgery c Volume 135, Number 5 991
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ANOVA 5 analysis of variance
GAPDH 5 glyceraldehyde-3-phosphate dehydrogenase
LAD 5 left anterior descending coronary artery
LV 5 left ventricular
LVEDP 5 left ventricular end-diastolic pressure
MI 5 myocardial infarction
PARP 5 poly (adenosine diphosphate–ribose)
polymerase
TUNEL 5 terminal deoxynucleotidyl transferase-mediated
dUTP nick-end labeling
VDAC 5 mitochondrial porin
remodeling have been shown to activate stretch-activated sig-
naling pathways and apoptotic molecular events.5,6
Studies have shown that myocyte apoptosis occurs in the
infarct, peri-infarct (adjacent), and remote zone of myocar-
dium after MI.7 Apoptosis is programmed cell death charac-
terized by cell shrinkage, membrane blebbing, and DNA
fragmentation.8,9 Both intrinsic and extrinsic pathways of
apoptosis leading to cell death have been described. The
intrinsic pathway relies on the release of mitochondrial
cytochrome c into the cytosol whereas the extrinsic pathway
relies on ligation of membrane-bound death receptors. Induc-
tion of either pathway leads to the activation of the aspartate-
specific cysteine proteases such as caspase-3 and cleavage of
poly (adenodiphosphate–ribose) polymerase (PARP).10,11
The objective of this study was to correlate changes in
remodeling strain (end-diastolic dimensional stretch) and
fractional contraction with molecular changes observed in
the infarct, adjacent, and remote regions of the myocardium
in a post-MI model of cardiac remodeling.
Methods
Study Design
Eight Dorsett hybrid sheep (male; weight, 60–70 kg) bred for labo-
ratory use (Thomas Morris, Reisterstown, Md) were instrumented
with subsequent creation of an anterolateral MI by coronary ligation.
Four noninstrumented animals served as healthy tissue controls. LV
geometry and function were measured with an echocardiogram.
Sonomicrometry transducers were placed in the free wall of the
LV to quantify the regional myocardial contractile function. At
the time of terminal study, LV myocardial tissue samples from the
excised heart from each animal were harvested in ice-cold solution
and separated into the infarct region, adjacent region (which was
defined as less than 2 cm from the edge of the infarct), and remote
region for analysis of protein expression. All the animals received
treatment in compliance with the ‘‘Guide for the Care and Use of
Laboratory Animals’’ published by the National Institutes of Health
(National Institutes of Health publication 85-23, revised 1996). The
surgical procedures and postoperative care were carried out accord-
ing to the approved protocol by the Institutional Animal Care and
Use Committee of the University of Maryland at Baltimore.992 The Journal of Thoracic and Cardiovascular Surgery c MaSurgical Protocol
In each animal, anesthesia was induced with thiopental sodium (10
mg/kg) and maintained by mechanical ventilation with 1% to 2%
isoflurane mixed with oxygen (Draeger anesthesia monitor; North
American Draeger, Telford, Pa). Surface electrocardiogram, arterial
blood pressure, pulse oximeter, and esophageal temperature were
continuously monitored during the surgical operation. The ins-
trumented group underwent a left anterolateral thoracotomy with
polypropylene snares placed around the first and second diagonal
coronary arteries of the left anterior descending artery (LAD) and
tunneled subcutaneously. The snares were momentarily tightened
(,30 seconds) to demarcate the border of the future infarct. Sixteen
sonomicrometry transducers (2 mm; Sonometrics Corporation, Lon-
don, Ontario, Canada) were placed in the free wall of the LV. The
transducers were placed in 3 groups, each having 5 transducers
placed circumferentially from anterior wall to posterior LV wall.
One transducer was placed at the LV apex. An ultrasound flow
probe (20 mm; Transonic Systems, Inc, Ithaca, NY) was placed
around the main pulmonary artery for cardiac output monitoring.
Infarction
Ten days after the initial operation, the sheep were reanesthetized.
The subcutaneous snares were permanently tightened to cause an
anterolateral MI and the animal was supported with epinephrine
infusion according to MI protocol described previously.12 The
pre-MI and post-MI data (sonomicrometry, echocardiogram, and
hemodynamics) were collected.
Data Collection and Analysis
Hemodynamic, echocardiographic, and sonomicrometry data were
collected in the pre-MI and post-MI periods and 2, 6, and 8 weeks
after MI. The hemodynamic parameters were measured with a Millar
pressure transducer (Millar Instruments, Inc, Houston, Tex) placed
in the LV cavity through the aortic valve via the femoral artery
with the aid of a fluoroscope. Parameters measured included heart
rate, systolic and diastolic arterial pressure, mean arterial pressure,
and LV end-diastolic pressure (LVEDP). Cardiac output was
measured with the transonic flow probe placed around the main pul-
monary artery with the flowmeter. Transdiaphragmatic echocardio-
graphic data were collected with a Sonos 5500 machine with a sterile
covered transducer (Philips Medical, Andover, Mass). LV end-
systolic and end-diastolic volumes, wall motion abnormalities, and
ejection fractions were measured as previously described.13 Sono-
micrometry data were collected with a commercially available digi-
tal sonomicrometry system (Sonometrics Corporation) to determine
3-dimensional motion and deformation of the LV free wall. Sono-
micrometry data were used to calculate the fractional contraction
(end-systolic strain) from end-diastole to end-systole over a cardiac
cycle to quantify the regional contractile function of the myocar-
dium. The end-diastolic and end-systolic time points were deter-
mined from the pressure and flow waveforms. Negative fractional
contraction values as percent change over diastolic reference indi-
cate functional contraction and positive values indicate dysfunc-
tional dilatation during systole. The remodeling strain calculated
between the geometries at end-diastole at one data collection time
point and at end-diastole at the pre-MI measurement was used to
quantify the progression of LV remodeling. We described the calcu-
lation of these strains previously.12 In brief, an area strain measurey 2008
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triangles between different time points. Strain measurements were
then calculated from the collected sonomicrometry transducer coor-
dinate data to compile (1) fractional strain during cardiac contraction
and (2) remodeling strain over the progression of myocardial remod-
eling as described above.
Immunohistochemistry Staining
The tissues sampled from the 3 regions (remote, adjacent, and in-
farct) were fixed in formalin for 24 hours, embedded in paraffin,
and 5-mm sections were obtained. The sections were then deparaffi-
nized with xylene and rehydrated with a series of graded alcohol.
The immunochemistry of cleaved caspase-3 was performed as pre-
viously described.14
Terminal Deoxynucleotidyl Transferase-mediated
dUTP Nick-end Labeling Analysis
Apoptotic cells were detected by terminal deoxynucleotidyl transfer-
ase-mediated dUTP nick-end labeling (TUNEL) with a commercially
available apoptosis detection kit (Roche Diagnostics, Indianapolis,
Ind). Histologic sections were prepared and stained according to
the manufacturer’s instructions. Positive control was prepared with
DNase I (3 mg/ml) (Roche Diagnostics) to induce DNA strand frag-
ments. Negative control was obtained by omitting terminal transfer-
ase during the labeling procedure. For cell death, tissue sections were
semiquantitatively evaluated by light microscopy (Carl Zeiss, Inc,
Oberkochen, Germany).
Western Blot Analysis
Protein extraction and Western blotting were performed as described
previously.12 Primary antibodies used were anti–caspase-3, anti–
cleaved caspase-3 (Asp175), anti-PARP, anti-VDAC (mitochondrial
porin; Cell Signaling Technology, Danvers, Mass), anti-Bax, and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibodies
(Santa Cruz Biotechnology, Santa Cruz, Calif).
Isolation of Myocardial Cytosolic Fraction
of Cytochrome c
Mitochondria were isolated from remote and adjacent regions of the
LV myocardium by a mitochondria-isolation kit for tissue (Pierce,
Rockford, Ill). Isolation of cytosolic fraction of cytochrome c was
performed as described previously.15 The soluble cystolic fraction
was assayed for cytochrome c. Western blot was performed with
specific anti–cytochrome c and GAPDH antibodies (Santa Cruz
Biotechnology) under the conditions recommended by the manufac-
turer.
Statistical Analysis
All data are expressed as the mean6 SEM. One-way repeated-mea-
sures analysis of variance (ANOVA) was used to compare temporal
changes in hemodynamic, echocardiographic, and strain data as well
as the abundance of protein expression. One-way ANOVA was used
to compare regional changes in strain data. All ANOVAs were per-
formed by multiple comparisons with the least significant difference
correction. The significance level was set at .05. Protein expression
was correlated with the regional strain to explore the association of
the strain with protein expression.The Journal of ThoResults
Hemodynamics
The heart rate, mean arterial pressure, and cardiac output re-
mained unchanged during the course of the study, but the
LVEDP progressively increased over the 10-week period.
The LVEDP at baseline, 30 minutes after MI, 2 weeks after
MI, 6 weeks after MI, and at terminal study were 1.4 6
0.4, 1.4 6 0.3, 3.9 6 0.7 (P , .05), 6.9 6 0.7 (P , .05),
and 8.1 6 0.8 mm Hg (P , .05), respectively.
Echocardiographic analysis
Figure 1 summarizes the echocardiographic data at the differ-
ent study time points. Results from the measurement of car-
diac function showed increases in LV end-diastolic volume
from 86.39 6 11.02 mL to 132.47 6 16.04 mL (P , .05)
and LV end-systolic volume from 40.49 6 8.15 mL to
93.466 12.85 mL (P, .05) with a decrease in ejection frac-
tion from 54.19% 6 5.68% to 30.55% 6 2.72 % (P , .05)
during the study period.
Strain Data
Figures E1 and E2 summarize the time-dependent regional
strain calculated from sonomicrometry. The fractional con-
traction values in the infarct, adjacent, and remote regions
of the LV myocardium decreased from 212.85% 6 1.48%
to 20.36% 6 0.79%, 214.05% 6 0.79% to 25.35% 6
0.76%, and 215.23% 6 1.20% to 214.69% 6 1.33%, re-
spectively, at terminal study. This implies the infarct zone
lost its contractile function (akinetic) immediately, the adja-
cent zone showed a gradual decrease in its fractional contrac-
tion (hypokinetic), and the remote zone remained almost
Figure 1. Summary of changes observed in left ventricular end-
systolic volume (LVESV), left ventricular end-diastolic volume
(LVEDV), and ejection fraction (EF) over time on echocardiogram.
Increase in LVEDV and LVSV with decrease in EF show a global
LV chamber dilatation and systolic dysfunction. All values are
given as mean 6 standard error of the mean. Symbols *, y, z,
and D indicate P# 0.05 as compared with preinfarct, postinfarct,
2 weeks, and 6 weeks, respectively.racic and Cardiovascular Surgery c Volume 135, Number 5 993
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the remodeling strain was measured as 51.06% 6 11.48%,
39.86% 6 8.47%, and 16.04% 6 5.02% in the infarct, adja-
cent, and remote regions of the LV myocardium, res-
pectively. Both the infarct and adjacent zones showed
significant degrees of dilatation during cardiac remodeling
whereas the remote region exhibited a lesser areal expansion.
TUNEL Analysis
Figure 2 shows photographs of typical TUNEL-stained sec-
tions of tissue from remote, adjacent, and infarct regions of
the LV myocardium. The nucleus of apoptotic cells stains
brown. The number of TUNEL-positive cells in the infarct
and adjacent regions of the myocardium was higher than in
the remote and normal tissues.
Immunohistochemistry Staining With Caspase-3
As expected, caspase-3 intensity was higher in the infarct re-
gion than in the adjacent and remote regions, as shown in Fig-
ure 2. The adjacent region showed mild caspase-3 activity
and the remote region stained for minimal caspase-3 activity.
Mitochondrium-mediated Apoptotic Protein
Expression
The infarct region showed more than a 2-fold increase in ex-
pression of mitochondrial Bax, cleaved caspase-3, and PARP
as compared with the remote region (Figure 3). There was no
significant regional change in the protein expression of cyto-
chrome c. Although the infarct region showed the most alter-
ation in the expression of cleaved caspase-3 and PARP from
normal, the remote region exhibited some level of caspase-3
and PARP activity.994 The Journal of Thoracic and Cardiovascular Surgery c MaCorrelation of Protein Expression With Strain
A positive relationship is observed for fractional contraction
versus expression of mitochondrial Bax (r25 0.27), cleaved
caspase-3 (r2 5 0.31), and PARP (r2 5 0.30), whereas
a weak relationship was demonstrated for cytochrome c
(r2 5 0.02). Likewise, a positive relationship was observed
for remodeling strain versus expression of mitochondrial
Bax (r2 5 0.28), cleaved caspase-3 (r2 5 0.43), and PARP
(r2 5 0.37), and a weak relationship was observed for cyto-
chrome c (r2 5 0.02). Figures 4 and 5 illustrate that the
more contractile and less remodeled the region of the myo-
cardium, the lower the expression of mitochondrial Bax,
cytochrome c, cleaved caspase-3, and PARP.
Discussion
Programmed cell death has been reported in patients with
several clinical heart diseases and experimental heart failure
models. Progressive cardiac remodeling is characterized by
progressive loss of myocytes in the adjacent region, thinning
of infarct wall, and chamber dilatation.16-18 Although necro-
sis as a form of cell death is the predominant process in the
infarct region in the first 24 to 48 hours after MI, apoptosis
is the major form of cell death during progressive cardiac re-
modeling after MI, with apoptosis higher in the adjacent re-
gion than remote region and control myocardium.16,19
There is increasing evidence that increased wall stress
from myocardial stretch (strain) during cardiac remodeling
induces the apoptotic pathway, and apoptotic cell loss con-
tributes to progressive ventricular dilation and systolic dys-
function.5,6,20 Apoptosis can be induced by stimuli with
membrane death receptor or by mitochondrium-mediated
pathway via the release of cytochrome c, resulting in the
downstream activation of caspase-3, an important moleculeFigure 2. The infarct region shows
a greater number of TUNEL-positive
cells and the highest caspase-3 inten-
sity. The adjacent region shows a lesser
number of TUNEL-stained cells with
a mild caspase-3 activity and remote re-
gion shows the fewest TUNEL-positive
cells with minimal caspase-3 staining.
Normal tissue is not shown but stained
similar to the remote region of the LV
myocardium.y 2008
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Relative abundance of protein expression: Poly
(ADP-ribose) polymerase (PARP), caspase-3, and
cytochrome c (Cyto c) normalized to glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) and
mitochondria Bax (Mito Bax) normalized to mito-
chondrial porin (VDAC). Symbols * and y indicate
P # .05 as compared with tissue in the adjacent
region and the infarction region of the LV myocar-
dium, respectively. All values are given as mean
6 SEM.in the determination phase of apoptosis.21 The pathway of
interest is via the mitochondrial origin, and on induction
of apoptosis, the mitochondrial membrane destabilizes
with translocation of cytosol Bax into the mitochondria
and altering the release of cytochrome c into the cytosol.22
Cytochrome c then activates caspase-9 and caspase-3
sequentially with resultant cleavage of PARP leading to
apoptosis.23,24
In the present study, apoptosis was documented histolog-
ically with the TUNEL assay and protein expression of
mediators by Western blot. Significantly higher levels of
proapoptotic Bax, cytochrome c, caspase-3, and PARP pro-
teins were seen in the adjacent region than remote region of
the myocardium. Results from our strain measurement indi-
cate that there are regional strain differences in the remote,
adjacent, and infarct regions of the myocardium after MIThe Journal of Thduring cardiac remodeling. Although there was a general in-
creasing trend in the remodeling strain, the largest increase
was found to be in the infarct region. The fractional contrac-
tion was noted to be decreasing from remote to the infarct
region. In this study, we investigated the relationship of
both the fractional contraction and remodeling strain (areal
dilatation) to alterations in apoptotic protein expression (mi-
tochondrial Bax, cytochrome c, caspase-3, and PARP) dur-
ing cardiac remodeling. Our results show a direct correlation
between apoptosis versus fractional contraction and remod-
eling strain during cardiac remodeling after MI. This obser-
vation is supported by the regional distribution of apoptosis
being significantly higher in the infarct region, in which
strain (mechanical stress) is typically higher than that in
the adjacent and remote regions of the myocardium. The re-
modeling changes were consistent with global changes inoracic and Cardiovascular Surgery c Volume 135, Number 5 995
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CSPFigure 4. Normalized cytochrome c, mi-
tochondrial Bax, caspase-3 and poly
(ADP-ribose) polymerse versus frac-
tional contraction. For abbreviations,
see Figure 3.vivo in LVDEP, echocardiogram-confirmed LV end-dia-
stolic volume, ejection fraction, and wall motion abnormal-
ities. Significant cardiac remodeling was observed by 8
weeks after MI in our ovine model as the LV chamber en-
larged, and significant increase in mechanical wall stress
(strain) induced with decreased fractional contraction in
the adjacent region of the myocardium and with compen-
satory hypercontractility in the remote region.25 These
changes during cardiac remodeling are associated with an
increase in angiotensin II, catecholamines, and various cyto-
kines and stretch stress, all of which are potential inducers of
apoptosis leading to cardiac functional impairment.26 Our
study indicates that regional activation of apoptosis corre-
lates strongly with fractional contraction and remodeling996 The Journal of Thoracic and Cardiovascular Surgery c Mastrain during cardiac remodeling. We speculate that myocar-
dial wall stretch (strain) through mechanotransduction is the
initial driving force and impetus behind myocardial apopto-
tic signaling cascade and myocardial cell death after MI dur-
ing progression of cardiac remodeling into heart failure.
Various studies have shown reversal of cardiac remodeling
and restoration of cardiac protein expression and function
by reducing myocardial strain in post-MI heart failure
models through LV assist devices, passive constraints, and
ventricular endocardial restoration procedures.27-29 It is our
hope that reducing myocardial strain by mechanically un-
loading the LV during cardiac remodeling will inhibit pro-
gressive apoptosis in the adjacent and remote regions of
the myocardium.Figure 5. Normalized cytochrome c, mi-
tochondrial Bax, caspase-3, and poly
(ADP-ribose) polymerase versus remod-
eling strain. For abbreviations, see
Figure 3.y 2008
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Discussion
Dr Robert C. Gorman (Philadelphia, Pa). This is an interesting
and potentially important study because you are trying to assess
how mechanical events in the heart that occur after an infarct affect
the biology of the remaining normally perfused myocardium.
As surgeons, we have focused primarily on influencing those
geometric properties with our surgical treatments for heart failure,
with the tacit assumption that the remaining myocardium is inher-
ently normal. This line of work is very important because it may
help to explain why our results for surgical heart failure are not as
good as we would expect after we return the heart to normal geom-
etry, being that the existing myocardium has some inherent changes
in it that have altered it beyond surgical repair.
That being said, I have 2 questions in regard to the technical
performance of your study and then one theoretical question with
regard to the therapeutic implications for your study.
You presented your sonomicrometry data that demonstrated the
regional contractile function, and I am a little concerned that the con-
tractile function within the infarct itself still showed contractile
properties. In our long experience with sonomicrometry in this
model, typically we see a very dyskinetic effect within the infarcts
demonstrating a lot of infarct expansion. You did not show that,
so I would be interested in your explaining that to us.
Second, when you are measuring cytochrome c, are you trying to
measure cytosolic cytochrome c?
Dr Yankey. Yes, sir.
Dr Gorman. I am a little concerned about your normal tissue,
which shows a tremendous amount of cytosolic cytochrome c,
which we would not expect to see. That is a typical problem with
trying to measure that property. You have to degrade the myocar-
dium, and you wind up banging up the mitochrondia and gettomg
cytochrome c all over the place. It is an important end point, but
we found it difficult to measure.
Dr Yankey. With regard to the first question pertaining to the
fractional contraction of the infarct region, we looked at about 8
sheep and we took an average of the various fractional contraction
values. When we looked at it over an 8-week period, it was a positive
value that indicates dysfunctional dilatation of the heart.racic and Cardiovascular Surgery c Volume 135, Number 5 997
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values showing the dilatation, but we evaluated only an 8-week pe-
riod. I believe that if we had looked longer than that, we would have
seen much greater positive values of the fractional contraction.
Pertaining to cytosolic cytochrome c, I do understand the prob-
lem you are addressing, but it was very difficult to actually get the
normal value. We just did the best that we could. That is the main
reason why we chose to also look at the mitochondrial Bax and
then show the values for caspase 3 and PARP as well. I do under-
stand, but that was the best that we could do to show that.
Dr Gorman. I want to expand on my question. The issue is that
you showed how stretch affects, potentially, apoptosis. Should we be
trying to treat mechanical stretch early with surgical means or should
we be looking for pharmacologic techniques for preventing apoptosis?998 The Journal of Thoracic and Cardiovascular Surgery c MayDrYankey. I think we should try to treat stretch in the earlier
phases, so that we can at least prevent the progressive apoptotic
cell loss in the adjacent regions and then the ongoing problem
in the remote areas as well. It is very important that we do in-
tervene as soon as possible so that we can prevent this apoptotic
cascade.
Dr Gorman. One other thing: When you do your correlation
analysis with your apoptosis and stretch, you really should not put
your infarct data in that. Apoptosis in the infarct, of which you
showed a tremendous amount, is not really the phenomenon we
are interested in. We are interested in apoptosis in the normally per-
fused regions. I am not sure that apoptosis in the infarct is not a good
thing. That may be associated with scar remodeling and things like
that. That is one thing to consider.2008
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Figure E1. Summary of changes observed in frac-
tional contraction and in infarct, remote, and ad-
jacent zones of LV myocardium at different study
time points. The infarct region shows loss of
contractile immediately after the MI becoming
akinetic. Adjacent region shows a statistically
significant loss of functional contraction by 2
weeks and becomes hypokinetic by 6 to 8 weeks.
The remote region shows preserved contractile
function by the end of the study. All values are
given as mean 6 SEM. Symbols * and y indicate
P # .05 as compared with remote and adjacent
regions, respectively. Symbols z and D indicate
P# .05 as compared with preinfarct and 6 weeks,
respectively.The Journal of Thoracic and Cardiovascular Surgery c Volume 135, Number 5 998.e1
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Figure E2. Summary of changes observed in re-
modeling strain in infarct, remote, and adjacent
zones of LV myocardium at different study time
points. The infarct displays the greatest remodel-
ing strain. The difference in the degree of remod-
eling between the adjacent and the remote zones
is statistically significant at both 6 weeks and
time of termination. All values are given as
mean 6 SEM. Symbols * and y indicate P # .05
as compared with remote and adjacent regions,
respectively. Symbols z, D, and # indicate P# .05
as compared with postinfarct, 2 weeks, and 6
weeks, respectively.998.e2 The Journal of Thoracic and Cardiovascular Surgery c May 2008
